KONNANCE
Live / Applied — Third extension granted (statement of use) (as of 05 Feb 2026)
What this means for you
Not registered yet, but its 16 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97937992
- Mark type
- Design + words
- Filed
- 16 May 2023
- Published for opposition
- 06 Aug 2024
- Attorney of record
- Brian J. Focarino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseases, disorders and conditions; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating schizophrenia, major depressive disorder, insomnia, mood disorder, negative symptoms, cognitive disorders, Parkinson's disease; pharmaceutical preparations for blocking serotonin receptors and sigma receptors
Owner
- Minerva Neurosciences, Inc., Burlington, MA, US
- Minerva Neurosciences, Inc., Burlington, MA, US
Prosecution history
- 05 Feb 2026 — SOU EXTENSION 3 GRANTED
- 05 Feb 2026 — SOU EXTENSION 3 FILED
- 05 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 24 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Sept 2025 — SOU EXTENSION 2 GRANTED
- 24 Sept 2025 — SOU EXTENSION 2 FILED
- 24 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Mar 2025 — SOU EXTENSION 1 GRANTED
- 24 Mar 2025 — SOU EXTENSION 1 FILED
- 24 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2024 — PUBLISHED FOR OPPOSITION
- 17 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED